Symbols

PRME

Prime Medicine·NASDAQ

--(--)

PRME fundamentals

PRME Q3 2025 Earnings

Prime Medicine (PRME) released its earnings on Nov 7, 2025: revenue was 1.23M (YoY +499.02%), missed estimates; EPS was -0.32 (YoY +27.27%), missed estimates.

Revenue / YoY

1.23M

+499.02%

EPS / YoY

-0.32

+27.27%

Report date

Nov 7, 2025

Earnings

EPS

Revenue

Revenue & Expenses

PRME has released its 2025 Q4 earnings report, with revenue of 838.00K, reflecting a YoY change of -61.61%, and net profit of -46.08M, showing a YoY change of -9.00%. The Sankey diagram below clearly presents PRME's revenue sources and cost distribution.

Key Indicators

Prime Medicine (PRME) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Prime Medicine (PRME)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Prime Medicine (PRME)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Prime Medicine (PRME)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown